 Circumvention multi-drug resistance human kidney kidney carcinoma vitro report calmodulin inhibitor trifluoperazine multi-drug resistance primary tissue cultures human kidney kidney carcinoma detection inherent multi-drug resistance expression P-glycoprotein immunofluorescence immunocytochemistry monoclonal antibody detection doxorubicin resistance reversal resistance trifluoperazine incorporation nucleic acid precursor addition doxorubicin trifluoperazine P-glycoprotein expressing resistant normal malignant kidney tissue cultures trifluoperazine sensitive normal kidney kidney carcinoma cultures little affected trifluoperazine circumvention primary resistance cells important implications use resistance modifiers clinical setting